Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 -1.15%
Revenue Growth %: +5.5%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +5.5%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
(Updated - January 21, 2026 8:28 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.43-$11.63, versus the consensus of $11.49. Johnson & Johnson sees FY2026 revenue of $100-101 billion, versus the consensus of $98.9 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Molson Coors Brewing (TAP) dropped from S&P 500
- Boeing wins $241 million Navy contract for aircraft repairs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
